Responses
Regular and Young Investigator Award Abstracts
Immune-Stimulants and Immune Modulators
1080 Using site-specific chemical conjugation to generate superior half-life extended or PD-1-targeted formats of a potent IL-18 variant resistant to IL-18 binding protein
Compose a Response to This Article
Other responses
No responses have been published for this article.